For Wegovy (once-weekly semaglutide) , recommendations depend on several factors including: Your individual risk profile Whether you're in the dose escalation phase The presence of significant gastrointestinal symptoms Local endoscopy unit policies Many patients can safely continue Wegovy before colonoscopy under moderate sedation
Patients should specifically inform their doctor if they have a history of the following conditions : thyroid disorders or thyroid nodules, pancreatitis or elevated pancreatic enzymes, kidney disease, liver disease, diabetic retinopathy, depression or suicidal ideation, gastroparesis or severe gastrointestinal disorders, or gallbladder disease
This medication has been thoroughly vetted for safety and efficacy
Cryo-EM data acquisition The concentrated sample (3.5 L) was applied to glow-discharged holey carbon grids (Quantifoil R1.2/1.3, 300 mesh), and subsequently vitrified using a Vitrobot Mark IV (ThermoFisher Scientific) set at 100% humidity and 4C